Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongshuan Jiuxin Pill
- Development stage
- Unknown
- Lead developer
- Xi'An Jinhua Enterprise Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongshuan Jiuxin Pill is a Traditional Chinese Medicine (TCM) developed by Jinhua Enterprise (Group) Co., Ltd. for the treatment of cardiovascular conditions, specifically chronic stable angina pectoris and coronary heart disease. Formulated as a multi-ingredient herbal product, it typically contains active components such as Panax ginseng, Panax notoginseng, Borneolum Syntheticum, and Amber. The therapeutic rationale is based on the TCM principles of promoting blood circulation, resolving blood stasis, and relieving pain. Pharmacologically, the pill acts by improving coronary blood flow, reducing myocardial oxygen consumption, and inhibiting platelet aggregation. It is primarily used to alleviate symptoms like chest pain, palpitations, and shortness of breath in patients exhibiting Qi deficiency and blood stasis patterns.
- Brand names
- Tongshuan Jiuxin Pill
- Other names
- Tongshuan Jiuxin WanTongshuan Jiuxin Pills
02
Targets
NOS1 (nNOS)ET (Endothelin receptors)
Beyond the preview
Go deeper on Tongshuan Jiuxin Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongshuan Jiuxin Pill.